Document Detail

Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.
MedLine Citation:
PMID:  23537757     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: To examine the outcomes in patients with and without a comorbid neurologic diagnosis (ND) or neurogenic bladder dysfunction after a staged neuromodulation procedure for refractory bladder symptoms.
MATERIALS AND METHODS: Patients enrolled in our prospective neuromodulation database study were grouped according to the presence of a coexisting ND. The implantable pulse generator implant rates were evaluated. Those who had received an implantable pulse generator were further evaluated over time for complications, revisions, explantations, and reprogramming sessions collected from the medical records. The symptom changes from baseline over 2 years were measured using patient-completed voiding diaries, the Interstitial Cystitis Symptom-Problem Index, Overactive Bladder Questionnaire, the Medical Outcomes Study short form, 12-item health survey, version 2, physical and mental component subscales, and a scaled global response assessment. The data were examined using Pearson's chi-square test or Fisher's exact test, Wilcoxon rank tests, and repeated measures analyses.
RESULTS: Of 340 patients, 63 of 71 (88.7%) with an ND and 241 of 269 (89.6%) without an ND had an implantable pulse generator implanted (P = .82). The NDs consisted of stroke (n = 17), multiple sclerosis (n = 13), Parkinson's disease (n = 10), incomplete spinal cord injury (n = 4), cerebral palsy (n = 1), and others. The complications, revisions/explants, and reprogramming sessions were similar between the 2 groups. Statistically significant improvements were seen in both groups over time on the voiding diary variables (except for incontinence episodes and severity in the ND group), Interstitial Cystitis Symptom-Problem Index, and Overactive Bladder Questionnaire. The short form, 12-item, physical and mental component subscale scores only improved significantly in those without an ND. Most patients (>50%) in both groups reported moderate or marked improvement in overall bladder symptoms at each point using the global response assessments.
CONCLUSION: Patients with neurogenic bladder dysfunction experience benefits after neuromodulation similar to the benefits experienced by those without coexisting neurologic conditions.
Kenneth M Peters; Pridvi Kandagatla; Kim A Killinger; Cheryl Wolfert; Judith A Boura
Related Documents :
15121387 - Localization of extraocular muscles during secondary orbital implantation surgery: the ...
21740987 - Influence of glycosaminoglycan identity on vocal fold fibroblast behavior.
23311617 - Implant and prosthodontic survival rates with implant fixed complete dental prostheses ...
20090477 - Inferolateral migration of hydrogel orbital implants in microphthalmia.
12483697 - Histocompatibility of photocrosslinked polyanhydrides: a novel in situ forming orthopae...
17395377 - Electron field emission properties of co quantum dots in sio2 matrix synthesised by ion...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Urology     Volume:  81     ISSN:  1527-9995     ISO Abbreviation:  Urology     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0366151     Medline TA:  Urology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  738-44     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Beaumont Health System, Royal Oak, MI; Oakland University William Beaumont School of Medicine, Rochester, MI.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Eurasiaplex: A forensic SNP assay for differentiating European and South Asian ancestries.
Next Document:  Hook wire localization for testis sparing surgery.